Department of Nephrology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, Hunan Province, China.
Key Laboratory of Biological, Nanotechnology of National Health Commission, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Clin Exp Med. 2024 Apr 2;24(1):66. doi: 10.1007/s10238-024-01318-y.
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) patients with dual positivity for proteinase 3-ANCA (PR3-ANCA) and myeloperoxidase-ANCA (MPO-ANCA) are uncommon. We aimed to investigate these idiopathic double-positive AAV patients' clinical features, histological characteristics, and prognosis. We reviewed all the electronic medical records of patients diagnosed with AAV to obtain clinical data and renal histological information from January 2010 to December 2020 in a large center in China. Patients were assigned to the MPO-AAV group or PR3-AAV group or idiopathic double-positive AAV group by ANCA specificity. We explored features of idiopathic double-positive AAV. Of the 340 patients who fulfilled the study inclusion criteria, 159 (46.76%) were female, with a mean age of 58.41 years at the time of AAV diagnosis. Similar to MPO-AAV, idiopathic double-positive AAV patients were older and had more severe anemia, lower Birmingham Vasculitis Activity Score (BVAS) and C-reactive protein (CRP) levels, less ear, nose, and throat (ENT) involvement, higher initial serum creatinine and a lower estimated glomerular filtration rate (eGFR) when compared with PR3-AAV (P < 0.05). The proportion of normal glomeruli of idiopathic double-positive AAV was the lowest among the three groups (P < 0.05). The idiopathic double-positive AAV patients had the worst remission rate (58.8%) among the three groups (P < 0.05). The relapse rate of double-positive AAV (40.0%) was comparable with PR3-AAV (44.8%) (P > 0.05). Although there was a trend toward a higher relapse rate of idiopathic double-positive AAV (40.0%) compared with MPO-AAV (23.5%), this did not reach statistical significance (P > 0.05). The proportion of patients who progressed to ESRD was 47.1% and 44.4% in the idiopathic double-positive AAV group and MPO-AAV group respectively, without statistical significance. Long-term patient survival also varied among the three groups (P < 0.05). Idiopathic double-positive AAV is a rare clinical entity with hybrid features of MPO-AAV and PR3-AAV. MPO-AAV is the "dominant" phenotype in idiopathic double-positive AAV.
抗中性粒细胞胞浆抗体(ANCA)相关性血管炎(AAV)患者同时存在蛋白酶 3-ANCA(PR3-ANCA)和髓过氧化物酶-ANCA(MPO-ANCA)阳性的情况并不常见。本研究旨在探讨这些特发性双阳性 AAV 患者的临床特征、组织学特征和预后。我们回顾了 2010 年 1 月至 2020 年 12 月期间在中国一家大型中心的所有电子病历,以获取患者的临床数据和肾组织学信息,这些患者被诊断为 AAV。根据 ANCA 特异性,患者被分配到 MPO-AAV 组、PR3-AAV 组或特发性双阳性 AAV 组。我们探讨了特发性双阳性 AAV 的特征。在符合研究纳入标准的 340 名患者中,159 名(46.76%)为女性,AAV 诊断时的平均年龄为 58.41 岁。与 MPO-AAV 相似,特发性双阳性 AAV 患者年龄更大,贫血更严重,Birmingham 血管炎活动评分(BVAS)和 C 反应蛋白(CRP)水平更低,耳、鼻、喉(ENT)受累更少,初始血清肌酐更高,估算肾小球滤过率(eGFR)更低(P<0.05)。三组中,特发性双阳性 AAV 的正常肾小球比例最低(P<0.05)。三组中,特发性双阳性 AAV 的缓解率最差(58.8%)(P<0.05)。双阳性 AAV 的复发率(40.0%)与 PR3-AAV(44.8%)相当(P>0.05)。尽管特发性双阳性 AAV 的复发率(40.0%)有高于 MPO-AAV(23.5%)的趋势,但未达到统计学意义(P>0.05)。特发性双阳性 AAV 组和 MPO-AAV 组分别有 47.1%和 44.4%的患者进展为终末期肾病,差异无统计学意义。三组患者的长期生存率也不同(P<0.05)。特发性双阳性 AAV 是一种罕见的临床实体,具有 MPO-AAV 和 PR3-AAV 的混合特征。MPO-AAV 是特发性双阳性 AAV 的“主要”表型。